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1. Introduction
1.1. Background as provided by the European Commission1
The judgment of the Court of Justice of the European Union in Case C-528/16 on mutagenesis has
clarified that Directive 2001/18/EC2 is applicable to genetically modified organisms (GMOs) obtained by
mutagenesis techniques that have emerged since its adoption (‘new mutagenesis techniques’).
Directive 2001/18/EC regulates the deliberate release of GMOs into the environment. In 2010, the
EFSA Panel on Genetically Modified Organisms issued the Guidance on the environmental risk
assessment of genetically modified (GM) plants (EFSA GMO Panel 2010) and in 2011 the Guidance on
the risk assessment of food and feed from GM plants (EFSA GMO Panel 2011). Following a request of
the European Commission, in 2012 EFSA published a Scientific opinion addressing the safety
assessment of plants developed using zinc finger nuclease 3 and other site-directed nucleases with
similar function (SDN-3) (EFSA GMO Panel (2012a), hereafter ‘EFSA Scientific Opinion on SDN-3’). In
this Scientific Opinion, the assessment methodology applied by the EFSA GMO Panel was to compare
the hazards associated with plants produced by the SDN-3 technique with those obtained by
conventional plant breeding techniques and by currently used transgenesis. Among the conventional
plant breeding techniques, the EFSA GMO Panel considered certain mutation breeding techniques that
emerged before the adoption of Directive 2001/18/EC and that are used as a tool to create genetic
variation.
The Scientific Opinion concluded that ‘the SDN-3 technique can minimise hazards associated with
the disruption of genes and/or regulatory elements in the recipient genome. Whilst the SDN-3
technique can induce off-target changes in the genome of the recipient plant, these would be fewer
than those occurring with most mutagenesis techniques. Furthermore, where such changes occur, they
would be of the same types as those produced by conventional breeding techniques.’
The EFSA GMO Panel also concluded that its 2010 and 2011 guidance documents ‘are applicable for
the evaluation of food and feed products derived from plants developed using the SDN-3 technique
and for performing an environmental risk assessment. However, on a case-by-case basis lesser
amounts of event-specific data may be needed for the risk assessment of plants developed using the
SDN-3 technique.’
1.2. Background as provided by EFSA
Following a request from the European Commission (Ref. Ares(2019)2488590-09/04/2019), in April
2019 EFSA assigned the mandate to the molecular characterisation working group of the GMO
Panel (Ref. BU/GdS/KL/FA/cz_OC-2019-21268932). To allow for public consultation, EFSA asked the
European Commission to change the Scientific Opinion deadline (Ref. BU/GdS/EW(2019)OC-2019-
22763474) which was then extended from 30 April 2020 to 30 October 2020 (Ref. Ares(2020)250930-
15/01/2020).
1.3. Terms of reference1
Against this background, the European Commission, in accordance with Article 29 of Regulation
(EC) No 178/20023, asked EFSA to address the following two terms of reference (ToR):
1) To advise whether the assessment methodology described in section 4 of the EFSA scientific
opinion addressing the safety assessment of plants developed using Zinc Finger Nuclease 3
and other Site-Directed Nucleases with similar function may be applicable, in whole or in part,
to plants developed with type 1 and type 2 site-directed nucleases and with oligonucleotide-
directed mutagenesis.
1 The text of this section was provided by the European Commission as part of the mandate’s documentation. The document
[Annex to letter (ToR)] can be found in the EFSA register of questions at http://registerofquestions.efsa.europa.eu/roqFrontend/
questionsListLoader?mandate=M-2019-0095
2 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the
environment of genetically modified organisms and repealing Council Directive 90/220/EEC - Commission Declaration. OJ L 106,
17.4.2001, p. 1–39.
3 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in
matters of food safety. OJ L 31, 1.2.2002, p. 1–24.
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If the advice to ToR1 is affirmative, the Commission would ask EFSA, in accordance with Article 29
of Regulation (EC) No 178/2002:
2) To advise whether the conclusions of the EFSA 2012 Scientific opinion addressing the safety
assessment of plants developed using Zinc Finger Nuclease 3 and other Site-Directed
Nucleases with similar function are valid, in whole or in part, to plants developed with type 1
and type 2 site-directed nucleases and with oligonucleotide-directed mutagenesis.
2. Data and methodologies
To address the two terms of reference, the molecular characterisation working group (MC WG) took
into consideration both section 4 and the overall conclusions of the EFSA Opinion on SDN-3 and the
relevant information reported in the scientific literature. Background information, the content of
section 4, and the overall conclusions of the EFSA Opinion on SDN-3 are provided in Section 2.1
below.
2.1. EFSA Opinion on SDN-3
2.1.1. Background information
In 2012, EFSA issued two Opinions on new plant breeding techniques, the first on cisgenesis and
intragenesis (EFSA GMO Panel, 2012b) and the second on SDN-3 (EFSA GMO Panel, 2012a). To
develop the Opinion on SDN-3, the GMO Panel was asked: i) to determine the risks in terms of the
impact on humans, animals and the environment that ZFN-3 could pose, by comparing plants
developed using ZFN-3 techniques with plants obtained by conventional plant breeding techniques and
with plants obtained with currently used genetic modification techniques; and ii) to determine whether
there was a need for new guidance on the risk assessment of plants generated using ZFN-3
techniques or whether the existing guidance on food and feed risk assessment (EFSA GMO Panel,
2011) and on environmental risk assessment of GM plants (EFSA GMO Panel, 2010) should be updated
or further elaborated. It should be noted that the guidance on food and feed risk assessment (EFSA
GMO Panel, 2011) was superseded by Implementing Regulation (EU) No 503/20134.
To develop the Scientific Opinion on SDN-3, the GMO Panel compared plants developed using SDN-
3 methods with plants obtained by conventional breeding, including the use of both spontaneous and
induced mutations (EFSA GMO Panel 2012a).
2.1.2. Section 4 of the EFSA Opinion on SDN-3
Section 4 of the EFSA Opinion on SDN-3 focuses on the hazards associated with plants that are
produced using SDN-3 methods that are used to target the insertion of transgenes, intragenes or
cisgenes to a specific plant genomic locus. The GMO Panel concluded that:
‘Hazards that might result from various plant breeding techniques are related to the source of
genes used, the genes and traits deployed and changes to the structure, organisation and sequence of
the recipient genome. The primary drivers are the genetic alterations that various breeding processes
introduce into the plants, as all other changes that take place are direct or indirect consequences of
these changes. Hazards regarding these alterations may arise both in conventional breeding and in
transgenesis.
‘The ZFN-3 technique, and SDN-3 in general, is used for targeted insertion of DNA. With respect to
the genes introduced, the SDN-3 technique does not differ from the other genetic modification
techniques currently used, and can be used to introduce transgenes, intragenes or cisgenes. The
hazards related to the source of genes have been described by EFSA (EFSA GMO Panel 2012b).
‘The SDN-3 technique makes use of the same transformation techniques as transgenesis, although
both transient and stable expression of the SDN can be used to introduce the site-specific DSB
[double-strand break]. In the case of stable integration of the SDN genes, they can subsequently be
removed by segregation to obtain plants containing only the integrated gene’ (EFSA GMO Panel,
2012a).
4 Commission Implementing Regulation (EU) No 503/2013 of 3 April 2013 on applications for authorisation of genetically
modified food and feed in accordance with Regulation (EC) No 1829/2003 of the European Parliament and of the Council and
amending Commission Regulations (EC) No 641/2004 and (EC) No 1981/2006. OJ L 157, 8.6.2013, p. 1–48.
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2.1.3. Conclusions of the EFSA Opinion on SDN-3
In the overall conclusions of the EFSA Opinion on SDN-3, the GMO Panel stated that:
‘The EFSA GMO Panel compared the hazards associated with plants produced by the SDN-3
technique with those associated with plants obtained by conventional plant breeding techniques and
by currently used transgenesis.
‘The main difference between the SDN-3 technique and transgenesis is that the insertion of DNA is
targeted to a predefined region of the genome. Therefore, the SDN-3 technique can optimise the
genomic environment for gene expression and minimise hazards associated with the disruption of
genes and/or regulatory elements in the recipient genome.
‘The SDN-3 technique can induce off-target changes but these would be fewer than those occurring
with most mutagenesis techniques. Where they do occur, the changes would be the same types as
those produced by conventional breeding techniques.
‘With respect to the genes introduced, the SDN-3 technique does not differ from the other genetic
modification techniques currently used, and can be used to introduce transgenes, intragenes or
cisgenes.
‘The EFSA GMO Panel considers that the Guidance for risk assessment of food and feed from
genetically modified plants (EFSA GMO Panel, 2011) and the Guidance on the environmental risk
assessment of genetically modified plants (EFSA GMO Panel, 2010) are applicable for the evaluation of
food and feed products derived from plants developed using the SDN-3 technique and for performing
an environmental risk assessment. However, on a case-by-case basis, lesser amounts of event-specific
data may be needed for the risk assessment of plants developed using the SDN-3 technique. There is
therefore a need for flexibility in the data requirements for risk assessments.’ (EFSA GMO Panel,
2012a)
2.2. Consultation
In line with its policy on openness and transparency, EFSA consulted EU Member States and its
stakeholders via an online public consultation. Between April and May 2020, interested persons were
invited to submit their comments on the draft GMO Panel Scientific Opinion.5 Following this
consultation process, the document was revised by the GMO Panel and the experts of the MC WG.
The outcome of the online public consultation is reported in an EFSA Technical report that will be
published on EFSA’s website together with the final Scientific Opinion.
3. Assessment
3.1. Introduction
3.1.1. Comparison of SDN-1, SDN-2 and ODM with SDN-3
An operational definition of site-directed nuclease (SDN) is provided by the Explanatory Note on
New Techniques in Agricultural Biotechnology from the Group of Chief Scientific Advisors, Scientific
Advice Mechanism (SAM) of the European Commission, as ‘an enzyme (endonuclease) that creates
site-specific double-strand breaks (DSBs) at defined sequences. SDN typically recognises a specific
DNA sequence and ‘cleaves’ DNA within such a sequence or nearby. The recognition of the DNA target
is mediated by the protein molecule itself (in protein-directed SDNs) or by an associated guide RNA
molecule (in RNA-directed SDNs).’ (European Commission, 2017).
Depending on the approach chosen when using an SDN, different outcomes are possible. In the
SDN-1 application, the plant non-homologous end-joining (NHEJ) repair pathway is exploited to
introduce random mutations (substitutions, insertions and deletions) at the target DSB site. Conversely,
the SDN-2 approach makes use of template DNA to generate a predicted modification (i.e. intended
sequence modification) at the target DSB site by exploiting the plant homology-directed repair (HDR)
pathway. Finally, the SDN-3 approach can exploit both NHEJ and HDR to insert a large stretch of DNA
in a targeted genomic location (EFSA GMO Panel, 2012a, Podevin et al., 2013).
ODM is set apart from SDN-based techniques because it does not rely on exogenous nucleases.
The Explanatory Note on New Techniques in Agricultural Biotechnology defines ODM as an approach
which is ‘[. . .] based on the use of oligonucleotides for the introduction of targeted mutations in the
5 Published at http://www.efsa.europa.eu/en/calls/consultations
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genome, usually of one or a few adjacent nucleotides. The genetic changes that can be obtained using
ODM include substitutions, insertions or deletions.’ (European Commission, 2017).
Overall, the application of SDN-1, SDN-2 and ODM methods results either in random (SDN-1) or
predicted (SDN-2 and ODM) mutations of a targeted genomic locus without the insertion of exogenous
DNA at the targeted locus. The aim of the SDN-3 approach is to modify the targeted locus by inserting
an exogenous DNA template of various lengths.
3.1.2. Technology used in SDN-1, SDN-2 and ODM applications
The EFSA Opinion on SDN-3 addressed the development and the application of technologies in the
area of plant genome editing up to the year 2012. In this regard, a literature review on zinc finger
nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and meganucleases was
included (section 2.1 of EFSA GMO Panel (2012a)). In this Scientific Opinion on SDN-1, SDN-2 and
ODM, the GMO Panel was not asked to deliver an extensive literature review on the technologies
deployed in these three approaches. However, considering the advances in genome editing that have
unfolded in recent years, the GMO Panel deemed it appropriate to include some information on them,
which is discussed below.
Since 2012, a new RNA-directed SDN-type technology known as the CRISPR/Cas system (clustered
regularly interspaced short palindromic repeats/CRISPR-associated nuclease) has emerged (Jinek et al.,
2012). Although there are still reports describing the use of ZFNs and TALENs for editing plant genes
and these technologies have been used to obtain products that are already on the market in the USA
(e.g. Calyno High Oleic Soybean Oil and Meal derived from genome-edited soybean using the TALENs
approach6), the CRISPR/Cas system has become de facto the preferred technology for genome editing
(Chen et al., 2019). The CRISPR/Cas system has been applied in genome editing across multiple plant
species, including model plants (see, e.g. Jiang et al. (2013), Li et al. (2013), Nekrasov et al. (2013))
and also crops like maize, sorghum, barley, potato, rice and wheat (see, e.g. Upadhyay et al. (2013),
Liang et al. (2014), Modrzejewski et al. (2019), Afzal et al. (2020)). So far, the ODM technology has
only been used to generate GM plants with relatively simple and easily selectable traits; e.g. herbicide
resistance (Sauer et al., 2016), and the amount of information available in the literature in terms of
the molecular mechanism, technological aspects, applications and intrinsic limitations of the system
(i.e. efficiency and specificity in different plant species) is considered limited compared with SDN-based
technologies such as the CRISPR/Cas system (Modrzejewski et al., 2019).
It should be noted that while ZFNs, TALENs, meganucleases and the CRISPR/Cas system can all be
used to achieve random (SDN-1) and predicted (SDN-2) mutations of a targeted genomic locus and
precise insertion of a DNA sequence (SDN-3), ODM is practically applied only to generate targeted
gene modifications which resemble those of the SDN-2 type. Other techniques which have recently
emerged such as base editing and prime editing (Komor et al., 2016; Anzalone et al., 2019; Lin et al.,
2020) can be used to generate specific nucleotide changes in a targeted sequence without deploying
any template DNA and without inducing DSB in the target locus. In this Scientific Opinion, the GMO
Panel considers that the genetic modifications obtained using base editing and prime editing are
comparable to those created by SDN-2 technology (see Section 3.1.1).
For a more extensive review of the technologies applied to generate genome-edited plants, the
GMO Panel refers the reader to the explanatory note of the EU Scientific Advice Mechanism (European
Commission, 2017) and to several comprehensive recent reviews (Doudna and Charpentier, 2014;
Komor et al., 2017; Chen et al., 2019; Hua et al., 2019; Zhang, 2020).
3.1.3. Methods for delivering or expressing SDN in plants
In plants, site-directed mutagenesis can be achieved by the stable integration, the transient
expression, or the ‘DNA-free’ delivery of the molecular components necessary to achieve the genetic
mutation (hereafter, the SDN module). In the case of stable integration and for sexually propagated
crops, the SDN module can be removed by segregation. This step will probably not be performed for
commonly asexually (vegetatively) propagated crops. In general, in all those cases where the presence
of the SDN gene cassette in the final product is not desirable, transient expression could be a valid
alternative method to express the SDN module (Ma et al., 2017). For ‘DNA-free’ delivery, either the
messenger RNA expressing the nuclease, the protein itself (for TALENs, ZFNs and meganucleases) or
the ribonucleoprotein complex (for the CRISPR/Cas system) are directly delivered into the plant cell
6 https://calyxt.com/first-commercial-sale-of-calyxt-high-oleic-soybean-oil-on-the-u-s-market/
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without the use of any intermediate sequence of DNA (Metje-Sprink et al., 2019). The possibility to
deliver purified sequence-specific nucleases to a plant cell was first described in Nicotiana tabacum
using meganucleases and TALENs (Luo et al., 2015). Since then, DNA-free delivery methods have been
applied to several plant species including important crops like rice (Woo et al., 2015), wheat (Zhang
et al., 2016; Bilichak et al., 2019), maize (Svitashev et al., 2016) and soybean (Kim et al., 2017). For
ODM, the chemically synthesised oligonucleotide is directly delivered to the plant cell without the need
for any stable or transient expression system. ODM has been successfully applied to several crops like
maize (Zhu et al., 2000), rice (Okuzaki and Toriyama, 2004) and oilseed rape (Gocal et al., 2015).
Multiple delivery systems for SDN components have been tested for different plant tissues, including
PEG-fusion, electroporation and biolistics (for a review of CRISPR/Cas9 component delivery methods
see (Sandhya et al., 2020)).
3.2. ToR1 of the mandate: applicability of section 4 of the EFSA Opinion
on SDN-3 to plants obtained using SDN-1, SDN-2 and ODM
approaches
3.2.1. Introduction
In addressing ToR1 of the mandate, the GMO Panel assessed section 4 of the EFSA Opinion on
SDN-3, which compares the hazards associated with plants developed using SDN-3 approaches with
those associated with transgenic and conventionally bred plants,7 and assessed its applicability to
plants developed using SDN-1, SDN-2 and ODM applications. The GMO Panel envisages two possible
scenarios. In the first one, the full SDN module, part of it and any nucleic acid sequence intentionally
deployed during the genome editing process is present in whole or in part in the plant genome (see
section 3.1.3). In this case, the product would be risk assessed as a transgenic plant with regard to
the exogenous DNA integrated into the genome and as a gene-edited plant in relation to the target
sequence(s) which was modified via SDN-1, SDN-2 or ODM approaches. In the second scenario, the
SDN module and any nucleic acid sequence intentionally deployed during the genome editing process
is not present in the genome of the edited plant (see Section 3.1.3). In this case, the assessment will
only focus on the modification(s) resulting from the SDN activity. The assessment of section 4 of the
EFSA Opinion on SDN-3 is described in Section 3.2.2 below.
3.2.2. Assessment of section 4 of the EFSA Opinion on SDN-3
3.2.2.1. Assessment of section 4.1: source of genes and safety of gene products
SDN-1, SDN-2 and ODM approaches differ from SDN-3 and transgenesis in that they do not aim to
insert any DNA sequence but rather to modify an already existing endogenous sequence (see
Section 3.1.1). Depending on the nature of the gene/locus modified and the origin of the allele and
trait associated with the final product, the risk assessment process will necessarily take into
consideration the history of safe use. For example, two very different scenarios, in terms of knowledge
on the newly brought function, could be envisaged. On the one end, the new allele obtained through
genome editing and the associated trait characterising the final product are already present in a
consumed and/or cultivated variety of the same species. In this case, the risk assessment may focus
on the knowledge of that variety (the history of safe use) and specific data on the edited gene and its
product may not be needed. On the other end, the modified allele and associated trait present in the
final product have never been described before. In this case, data on the new allele and the
associated trait would be needed to perform the risk assessment. The GMO Panel considers that a
substantial number of different scenarios can be envisaged between these two possibilities, and
consequently, a range of data requirements may apply depending on the specific case. Depending on
the product under assessment, in some cases only a subset of the data required for SDN-3 would be
needed.
Because of all the above considerations, the GMO Panel concludes that section 4.1 of the EFSA
Opinion on SDN-3 (‘Source of genes and safety of gene products’) is applicable only in part to plants
developed by SDN-1, SDN-2 or ODM approaches.
7 From the EFSA Opinion on SDN-3: conventional breeding methods include a wide range of techniques (van der Wiel, et al.
2010). The EFSA GMO Panel considers the following techniques relevant for a comparison with plants developed by the SDN-3
technique: sexual crosses, bridge crosses, embryo rescue, somatic hybridisation, translocation breeding and mutation breeding.
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3.2.2.2. Assessment of section 4.2: alteration to the genome
3.2.2.2.1. Alteration at the insertion site (section 4.2.1)
SDN-1 and SDN-2 approaches use the same molecular mechanisms to induce DSBs as SDN-3.
Unlike the SDN-1 and SDN-2 approaches, the ODM approach is not designed to induce DSBs, and in
this respect, it is different from SDN-3. Moreover, the application of recent technological developments
in the area of genome editing (i.e. prime and base editing, see Section 3.1.2) does not induce DSB in
the plant genome at any stage during the process; rather, they induce in general a single strand break
at the target site. Irrespective of the approach used, the successful application of SDN-1, SDN-2 or
ODM results in a sequence modification which is targeted to a specific predetermined genomic locus
where no exogenous DNA is inserted. For these reasons, the considerations described in section 4.2.1
of the EFSA Opinion on SDN-3 which refers to: i) the targeted integration of the transgene, intragene
or cisgene mediated by SDN-3; ii) the possibility to add or exchange specific genes at their native loci;
and iii) the optimisation of the newly created junctions between the plant DNA and the inserted DNA,
are all irrelevant for plants obtained using SDN-1, SDN-2 or ODM approaches.
Because of all the above considerations, the GMO Panel concludes that section 4.2.1 of the EFSA
Opinion on SDN-3 (‘Alteration at the insertion site’) is not applicable to plants developed by SDN-1,
SDN-2 or ODM approaches.
3.2.2.2.2. Alteration elsewhere in the genome (section 4.2.2)
The application of SDN-1, SDN-2 or ODM approaches aims to modify a predetermined plant
genomic sequence. However, it can also introduce changes elsewhere in the genome because of the
off-target activity associated with these applications and their processes (Hahn and Nekrasov, 2019).
The off-target activity depends not only on the specificity of the technology used but also on the
presence and accessibility of sequences which share a certain level of sequence similarity with the
original target locus. In addition, some base editing systems have been shown to present Cas9-
independent off-target effects linked to the base editor activity itself (Jin et al., 2019; Zuo et al.,
2019). For these reasons, SDN-1, SDN-2 or base editing off-target activity might result in unintended
mutations outside the original target sequence that can either be predictable (for SDN-1 and SDN-2)
or not (for some base-editing systems) (Jin et al., 2019; Naeem et al., 2020). In recent years,
considerable effort has been directed to the improvement of the efficiency and specificity of SDN-
based technologies, particularly for the CRISPR/Cas system (including base editing; see Doman et al.
(2020), Deng et al. (2020), Anzalone et al. (2020)). For example, designing shorter gRNAs or their
improved design (Young et al., 2019), lowering intracellular concentration of the Cas-gRNA complex
(Pattanayak et al., 2013), expressing specific anti-CRISPR proteins (Hoffmann et al., 2019), or RNP
delivery (Svitashev et al., 2016) seem to generally reduce off-target effects. Moreover, the
development (and/or the identification) of other CRISPR-associated nucleases has helped to improve
efficiency and specificity and reduce off-target effects (Veillet et al., 2020).
In the EFSA Opinion on SDN-3, the GMO Panel concluded that the off-target mutations induced by
the application of SDN-3 approaches are fewer than those occurring when applying conventional
mutagenesis techniques that have been used previously and have a long history of safe use. In
addition, backcrossing following the transformation process can be used to remove these potential off-
target mutations from the final product, except for those that are genetically linked to the intentionally
modified locus (EFSA GMO Panel, 2012a). Following the publication of the SDN-3 Opinion,
experimental evidence has been published describing the type and number of off-target mutations
generated by the application of SDN-based methods (Tang et al., 2018; Lee et al., 2019; Li et al.,
2019). These publications confirmed that the off-target mutations potentially induced by SDNs are of
the same type as those mutations used in conventional breeding, including spontaneous mutations and
those produced by physical and chemical mutagenesis. Moreover, these publications also confirmed
that the number of off-target mutations generated by SDN-based methods is lower than the number
of mutations observed in conventional breeding due to spontaneous or induced mutations (Tang et al.,
2018; Lee et al., 2019; Li et al., 2019). Therefore, the GMO Panel considers that the analysis of
potential off-targets would be of very limited value for the risk assessment. In addition, although some
biochemical and bioinformatic tools are available to identify potential off-target mutations (Bae et al.,
2014; Tsai et al., 2015; Cameron et al., 2017; Akcakaya et al., 2018; Peng et al., 2018; Naeem et al.,
2020), the limited availability and/or completeness of plant genomic sequences and their intraspecies
and intravarietal variability would not always allow for a reliable prediction of potential off-target
mutations (Tang et al., 2018; Lee et al., 2019). While an increasing number of publications have
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investigated off-target effects for SDN-based technologies, the GMO Panel noticed that information on
the off-target mechanism and frequency for ODM is quite limited (Modrzejewski et al., 2019). Finally,
the EFSA Opinion on SDN-3 stated that backcrossing steps which follow the transformation process
would likely remove off-target mutations from the genome of the final product (see above). The GMO
Panel considers this aspect still applicable to plants generated via SDN-1, SDN-2 and ODM approaches.
When plant transformation is used to introduce the SDN module, the unintended insertion of
plasmid DNA or other exogenous DNA into the plant genome can happen. Furthermore, the application
of some methods (e.g. transient expression and DNA-free methods) to achieve SDN-1 and SDN-2
modifications can result in the unintended integration of exogenous DNA whose sequence may be
known a priori (examples of unintended on-target insertion of exogenous DNA can be found in Clasen
et al. (2016), Andersson et al. (2018), Norris et al. (2020), Solomon (2020)). If the final product is not
intended to retain any exogenous DNA, the applicant should assess the potential presence of a DNA
sequence derived from the methods used to generate the SDN modification (e.g. plasmids or vectors,
see Section 3.1.3). It should be noted that the assessment of the unintentional integration of
exogenous DNA is already part of the molecular characterisation in the risk assessment of GM plants,
under EU Regulations. Therefore, this is not to be considered a new requirement for risk-assessing
genome-edited plants.
Because of all the above considerations, the GMO Panel concludes that section 4.2.2 of the EFSA
Opinion on SDN-3 (‘Alteration elsewhere in the genome’) is applicable to plants developed by SDN-1,
SDN-2 or ODM approaches.
3.3. ToR2 of the mandate: applicability of the conclusions of the EFSA
Opinion on SDN-3 to plants obtained using SDN-1, SDN-2 or ODM
approaches
The EFSA GMO Panel (2012a) compared plants obtained by the application of the SDN-3 approach
with plants produced by conventional breeding techniques and by currently used transgenesis. In the
following section, the GMO Panel compared the hazards associated with plants produced via SDN-1,
SDN-2 or ODM approaches with those associated with plants obtained via the SDN-3 approach. In
addressing ToR2 of the mandate, the GMO Panel also considered its assessment reported in
Section 3.2 and evaluated the conclusions of the EFSA Opinion on SDN-3 (EFSA GMO Panel, 2012a).
The following considerations are raised:
1) The conclusion referring to the optimisation of the genomic context of the transgene, cisgene
or intragene insertion in SDN-3 plants is not applicable to plants obtained via SDN-1, SDN-2
or ODM approaches, since these methods aim to modify an endogenous DNA sequence
without the insertion of any transgene, intragene or cisgene.
2) The EFSA Opinion on SDN-3 concluded that the application of SDN-3 can induce off-target
mutations but these would be fewer than those occurring with most mutagenesis techniques.
Where they do occur, these changes would be the same types as those derived by
conventional breeding techniques (EFSA GMO Panel, 2012a). As SDN-1 and SDN-2 techniques
use the same molecular mechanisms to generate DSB as SDN-3, the conclusions for SDN-3
are also applicable to SDN-1 and SDN-2. In the case of ODM, although very limited
information on the mechanisms and frequency of off-target effect is available in the literature,
it is reasonable to assume that the same conclusions also apply because this technology is
based on sequence-specific site recognition, as are SDN-based methods.
3) The conclusion addressing the risk assessment of the introduced transgene, intragene or
cisgene is not applicable because of the reason outlined in point 1. However, the GMO
Panel considers that in some cases, the SDN module could be stably introduced as a
transgene in the plant genome. In these cases, the obtained plant should be considered a
transgenic plant and the presence of the transgene will be risk-assessed according to all the
provisions laid down in the EU regulation of GMOs.
4) In the EFSA Opinion on SDN-3, the GMO Panel concluded that the guidance for the risk
assessment of food and feed from GM plants (EFSA GMO Panel, 2011) and the guidance on
the environmental risk assessment of GM plants (EFSA GMO Panel, 2010) are applicable for
the risk assessment of plants obtained using the SDN-3 method. The GMO Panel considers
that the two EFSA guidance documents are sufficient but are only partially applicable to the
risk assessment of plants generated by the application of SDN-1, SDN-2 or ODM methods.
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Indeed, those requirements that relate to the presence of transgenes, intragenes or cisgenes
are not relevant because of the reason outlined in point 1. In the EFSA Opinion on SDN-3, the
GMO Panel also concluded that ‘on a case-by-case basis lesser amounts of event-specific data
are needed for the risk assessment’ (EFSA GMO Panel, 2012a). The GMO Panel considers that
this conclusion also applies to plants generated via SDN-1, SDN-2 or ODM approaches.
Indeed, in the absence of any transgene, intragenes or cisgenes, the amount of experimental
data needed for the risk assessment will mainly depend on the modified trait introduced and
even less experimental data would be needed for plants produced via SDN-1, SDN-2 or ODM
compared with plants generated via SDN-3.
4. Conclusions
In relation to ToR1, the GMO Panel concludes that the assessment methodology presented in
section 4 of the EFSA Opinion on SDN-3 is partially applicable to SDN-1, SDN-2 and ODM. Since these
approaches aim to modify an endogenous DNA sequence in a targeted manner, if the final product
does not contain any transgene, intragene or cisgene, these plants will not present any of the hazards
potentially associated with the inserted transgene, intragene or cisgene found in plants obtained using
the SDN-3 approach. Moreover, the GMO Panel did not identify any additional hazard associated with
the use of the SDN-1, SDN-2 or ODM approaches as compared with both SDN-3 and conventional
breeding techniques which include conventional mutagenesis. The SDN-1 and SDN-2 approaches can
induce off-target changes but, like for SDN3, these would be fewer than those occurring with classical
mutagenesis techniques, decreasing the risk of alteration or interruption of genes.
In relation to ToR2, the GMO Panel concludes that the existing guidance for food and feed (EFSA
GMO Panel, 2011) and environmental risk assessment (EFSA GMO Panel, 2010) is sufficient but is only
partially applicable for the risk assessment of plants generated via SDN-1, SDN-2 or ODM approaches.
Indeed, as SDN-1, SDN-2 and ODM aim to modify endogenous DNA sequence(s) without integrating
exogenous DNA, a number of requirements in the existing guidance that are linked to the presence of
a transgene are not relevant for the assessment of SDN-1, SDN-2 or ODM plants. The amount of
experimental data needed for the risk assessment will mainly depend on the modified trait introduced
and, therefore, the GMO Panel considers that the principle of a case-by-case approach to a risk
assessment is particularly relevant for SDN-1, SDN-2 and ODM plants.
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Abbreviations
DSBs double-strand breaks
GMO Genetically Modified Organisms
HDR homology-directed repair
MC WG molecular characterisation working group
NHEJ non-homologous end-joining
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ODM oligonucleotide-directed mutagenesis
SAM Scientific Advice Mechanism
SDN site-directed nuclease
TALENs transcription activator-like effector nucleases
ToR terms of reference
ZFNs zinc finger nucleases
Glossary
Backcrossing Cross (a hybrid) with one of its parents or an organism with the same
genetic characteristics as one of the parents
Cisgenesis The genetic modification of a recipient organism with a gene from a
crossable – sexually compatible – organism (same species or closely related
species) (EFSA GMO Panel, 2012b)
CRISPR Clustered regularly interspaced short palindromic repeats, a component of a
bacterial immunity used to recognise and protect against viruses. It is
commonly used as a shorthand for the CRISPR/Cas9 system
Double-strand break
(DSB)
The mechanical, chemical or enzymatical cleavage of both strands of the
DNA
Exogenous DNA DNA originating outside the plant being modified which can be introduced
naturally or by technological intervention
Genetically linked Genomic loci which are located in such close proximity that they are
inherited together during the meiosis in sexually propagated organisms
Genome The haploid set of chromosomes of a given organism which contains all the
genetic information necessary for its maintenance




Abbreviated to HDR, a molecular mechanism which allows the repair of
DNA double-strand breaks using a homologous sequence of DNA as
template
Intragenesis Genetic modification of a recipient organism that leads to a combination of
different gene fragments from donor organism(s) of the same or a sexually
compatible species as the recipient (EFSA GMO Panel, 2012b)
Non-homologous end
joining
Abbreviated to NHEJ, a molecular mechanism which allows the repair of
DNA double-strand breaks when a homologous sequence of DNA is not
available. In some cases, NHEJ results in genomic mutations, usually
insertion or deletion of fragments of DNA
Off-target mutation A genomic mutation which occurs in a genomic locus other than the
intended one as a result of the application of genetic engineering
techniques
Oligonucleotide A stretch of nucleic acid consisting of a relatively low number of nucleotides
Ribonucleoprotein A macromolecule complex composed of protein and RNA polymers




In this Opinion, a molecular biology method that is used to make specific




Abbreviated to SDN, an enzyme which recognises a specific sequence and
cleaves the DNA usually creating a double-strand break
SDN module In this Opinion, molecular components necessary to achieve the genetic
mutation
Transformation In this Opinion, the process by which a prokaryotic or eukaryotic cell takes
up exogenous DNA
Transgenesis The process of introducing gene(s) from a different, sexually incompatible,
species into the genome of a given cell and the propagation of such gene
(s) thereafter
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